An overview of animal cell substrates for biological products

Biologicals

Volumn 36, Issue 6, 2008, Pages 359-362

  Petricciani, John ^a   Sheets, Rebecca ^b  

^a JOHN WAYNE CANCER INSTITUTE   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

Biological products; Cell substrates; Vaccines

Indexed keywords

BIOLOGICAL PRODUCT; CELL DNA;

ARTICLE; CARCINOGENICITY; CELL GROWTH; CELL MATURATION; CONTAMINATION; IN VITRO STUDY; PHENOTYPE; PRIORITY JOURNAL; VACCINATION;

ANIMALS; BIOLOGICAL PRODUCTS; CELL CULTURE TECHNIQUES; CELL LINE; CELLS, CULTURED; CULTURE MEDIA; HELA CELLS; HUMANS; MAMMALS; PHENOTYPE;

ANIMALIA;

EID: 56949097741     PISSN: 10451056     EISSN: 10958320     Source Type: Journal    
DOI: 10.1016/j.biologicals.2008.06.004     Document Type: Article

References (8)

1. Hilleman M.R. Cells, vaccines, and the pursuit of precedent. NCI Monogr 29 (1968) 463-468
2. Hilleman M.R. Cell line saga - an argument in favor of production of biologics in cancer cells. Adv Exp Biol Med 118 (1979) 47-58
3. Hayflick L., Plotkin S., and Stevenson R.E. Acceptance of HDC strains. Dev Biol Stand 68 (1987) 9-17
4. Beale A.J. Choice of cell substrate for biological products. Adv Exp Biol Med 118 (1979) 83-97
5. In vitro cellular and developmental biology. In: Hopps H.E., and Petricciani J.C. (Eds). Monograph No.6: abnormal cells, new products, and risk (1985), : Tissue Culture Association, Gaithersberg, MD
6. Report of the meeting of the study group on biologicals 1987. WHO technical report series, No. 747.
7. Elmishad A.F., Bocchetta M., Pass H.I., and Carbone M. Polio vaccines, SV40 and human tumours, an update on false positive and false negative results. Dev Biol 123 (2006) 109-117
8. In: Petricciani J., and Sheets R. (Eds). Vaccine cell substrates 2004. Dev Biol (2006) Basel; Karger